Vribose 0.2mg Tablet
Marketer
Vrinda Life
Salt Composition
Voglibose (0.2mg)
Overview Vribose 0.2mg Tablet
Glucotrim 0.2mg tablets are prescribed for managing type 2 diabetes. This medication assists in regulating elevated blood glucose following meals, particularly when dietary adjustments and other similar medications prove insufficient. Glucotrim 0.2mg should be administered immediately before eating. Dosage and frequency are determined by your physician to optimize blood sugar control. Discontinuation should only occur under medical supervision; abrupt cessation may elevate blood sugar, potentially resulting in serious complications like renal impairment or vision loss. This treatment forms part of a comprehensive program encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Commonly reported side effects include bloating, abdominal discomfort, decreased appetite, bowel irregularity, and diarrhea. Report any persistent or bothersome side effects to your physician. While Glucotrim alone does not typically cause hypoglycemia, concurrent use with other diabetes medications (especially insulin or sulfonylureas) may increase this risk. Glucose tablets are the recommended treatment for hypoglycemic episodes; ordinary sugar may be ineffective. Inform your doctor about any existing kidney or liver conditions before commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should seek medical advice prior to use. Always disclose all current medications to your doctor to ensure medication safety. Limit alcohol consumption while taking Glucotrim, as it can heighten the risk of hypoglycemia.
Primary Ingredients of Vribose 0.2mg Tablet
No text provided to rephrase.
Uses of Vribose 0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Vribose 0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.2mg Vribose tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Vribose 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vribose 0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.2mg Vribose tablet whole; avoid crushing, chewing, or breaking it. Administer on an empty stomach.
How Vribose 0.2mg Tablet works:
Glucovance 0.2mg tablets are used to manage diabetes. These tablets work by blocking the enzymes in the intestines that digest complex carbohydrates into simple sugars like glucose, thus moderating post-meal blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vribose 0.2mg Tablet with alcohol is not advisable due to safety concerns.
PregnancySAFE IF PRESCRIBED
The use of 0.2mg Vribose tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, data from human studies remains scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of 0.2mg Vribose tablets appear compatible. Studies in humans show minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Vribose 0.2mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use 0.2mg Vribose tablets cautiously. Dosage modification of 0.2mg Vribose tablets may be necessary; physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use 0.2mg Vribose tablets cautiously. Dosage modification for Vribose 0.2mg tablets may be necessary; physician consultation is advised.
What if you forget to take Vribose 0.2mg Tablet :
Omit any missed Vribose 0.2mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Vribose 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavioral Class | Alpha-glucosidase inhibitors |
3,018 People bought this recently